🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/09/2006 | 27,25 | 28,39 | 27,11 | 28,07 | +3,41% | 4,72% | 1.070.600 |
| 11/09/2006 | 26,90 | 27,34 | 26,65 | 27,15 | +0,74% | 2,57% | 464.800 |
| 08/09/2006 | 26,83 | 27,13 | 26,62 | 26,95 | +0,90% | 1,90% | 647.400 |
| 07/09/2006 | 26,59 | 26,90 | 26,17 | 26,71 | +0,28% | 2,75% | 507.600 |
| 06/09/2006 | 27,00 | 27,04 | 26,28 | 26,63 | -1,88% | 2,83% | 841.800 |
| 05/09/2006 | 27,22 | 27,39 | 26,86 | 27,14 | -0,57% | 1,95% | 415.800 |
| 01/09/2006 | 27,53 | 27,58 | 26,97 | 27,30 | +0,00% | 2,20% | 412.600 |
| 31/08/2006 | 27,50 | 27,82 | 27,21 | 27,30 | -0,75% | 2,24% | 496.000 |
| 30/08/2006 | 27,13 | 27,73 | 26,89 | 27,50 | +1,85% | 3,12% | 972.800 |
| 29/08/2006 | 27,16 | 27,17 | 26,82 | 27,00 | -0,26% | 1,29% | 590.000 |
| 28/08/2006 | 26,75 | 27,25 | 26,55 | 27,07 | +1,39% | 2,64% | 520.400 |
| 25/08/2006 | 26,98 | 27,13 | 26,54 | 26,70 | -0,89% | 2,19% | 332.400 |
| 24/08/2006 | 27,29 | 27,39 | 26,79 | 26,94 | -1,52% | 2,20% | 477.000 |
| 23/08/2006 | 27,40 | 27,41 | 26,76 | 27,36 | +0,11% | 2,39% | 403.000 |
| 22/08/2006 | 27,41 | 27,65 | 27,03 | 27,33 | -0,49% | 2,28% | 463.800 |
| 21/08/2006 | 27,40 | 27,67 | 27,01 | 27,46 | -0,25% | 2,41% | 499.800 |
| 18/08/2006 | 27,95 | 27,95 | 27,36 | 27,53 | -1,04% | 2,13% | 492.000 |
| 17/08/2006 | 27,79 | 28,02 | 27,59 | 27,82 | -0,48% | 1,57% | 467.600 |
| 16/08/2006 | 27,70 | 28,05 | 27,50 | 27,96 | +1,91% | 2,00% | 1.099.600 |
| 15/08/2006 | 27,37 | 27,49 | 27,16 | 27,43 | +1,54% | 1,21% | 552.400 |
| 14/08/2006 | 27,34 | 27,44 | 26,69 | 27,02 | -0,44% | 2,74% | 539.200 |
| 11/08/2006 | 26,76 | 27,26 | 26,56 | 27,14 | +1,02% | 2,62% | 611.200 |
| 10/08/2006 | 27,10 | 27,15 | 26,66 | 26,86 | -0,79% | 1,79% | 765.400 |
| 09/08/2006 | 27,29 | 27,49 | 27,02 | 27,08 | +0,28% | 1,74% | 825.400 |
| 08/08/2006 | 27,41 | 27,63 | 26,80 | 27,00 | -0,95% | 3,03% | 847.600 |
| 07/08/2006 | 27,41 | 27,54 | 27,10 | 27,26 | -1,71% | 1,61% | 1.081.400 |
| 04/08/2006 | 27,68 | 28,08 | 27,27 | 27,74 | +0,89% | 2,91% | 1.017.600 |
| 03/08/2006 | 26,16 | 27,55 | 26,16 | 27,49 | +4,11% | 5,31% | 1.802.800 |
| 02/08/2006 | 26,25 | 26,56 | 25,92 | 26,41 | +0,78% | 2,44% | 1.383.200 |
| 01/08/2006 | 28,49 | 28,62 | 25,50 | 26,20 | -11,65% | 10,94% | 7.142.200 |